
Rabetouch 20 Tablet
Marketer
Meditouch Wellness
Salt Composition
Rabeprazole (20mg)
Overview Rabetouch 20 Tablet
GastroGard 20mg tablets lower stomach acid production. They treat acid-related stomach and intestinal disorders like gastroesophageal reflux disease (GERD), peptic ulcers, and Zollinger-Ellison syndrome, easing symptoms and fostering healing. Take one tablet an hour before meals, ideally in the morning, as directed by your physician; the dosage depends on your condition and response. Maintain consistent daily intake, even if symptoms subside rapidly. Dietary modifications, such as smaller, more frequent meals and avoiding caffeine, spicy foods, and fatty foods, may also help. Common side effects – nausea, vomiting, headache, dizziness, gas, diarrhea, and abdominal pain – are usually mild. Report persistent or bothersome side effects. Prolonged use (over a year), especially at higher doses, may increase bone fracture risk. Discuss bone health preservation, including calcium and vitamin D supplementation, with your doctor. Hypomagnesemia (low magnesium) can occur after three months or more of use, potentially causing fatigue, confusion, dizziness, muscle spasms, and irregular heartbeat. Your doctor may monitor your magnesium levels. This medication is unsuitable for some individuals. Inform your physician about severe liver disease, HIV medication use, prior allergic reactions to similar medications, or existing osteoporosis before starting treatment. Pregnant or breastfeeding women should consult their doctor. Avoid alcohol, as it stimulates excess stomach acid. Refrain from operating machinery or driving if dizziness or drowsiness occurs.
Uses of Rabetouch 20 Tablet
Managing gastroesophageal reflux, peptic ulcers, and Zollinger-Ellison syndrome.
Major Benefits of Rabetouch 20 Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Rabetouch 20 Tablet should be taken on an empty stomach.
Common Side effects of Rabetouch 20 Tablet:
- Diarrhea
- Dizziness
- Flatulence
- Headache
- Nausea
- Sore throat
- Stomach pain
- Vomiting
How to use Rabetouch 20 Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Rabetouch 20 Tablets should be administered on an empty stomach.
How Rabetouch 20 Tablet works:
Gastro-X 20mg tablets, a proton pump inhibitor, lessen stomach acid production, providing relief from heartburn and acid indigestion.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Rabetouch 20 Tablet with alcohol. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
Using Rabetouch 20 Tablet during pregnancy might pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Nursing mothers should likely avoid Rabetouch 20 Tablet. Available data from humans indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Using Rabetouch 20 Tablet may cause drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving is inadvisable if these effects are experienced.
KidneySAFE IF PRESCRIBED
Renal impairment does not necessitate dosage modification for patients using Rabetouch 20 Tablet; its use is considered safe in this population.
LiverSAFE IF PRESCRIBED
Patients with liver disease can safely use Rabetouch 20 Tablet without requiring any alteration to the prescribed dosage.
What if you forget to take Rabetouch 20 Tablet :
Should you forget a Rabetouch 20 Tablet dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Rabetouch 20 Tablet
| Label | Value |
|---|---|
| Chemical Type | Benzimidazole Sulfoxide |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
| Behavioral Class | Gastric acid suppressants |
